Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 40 for Clostridium difficile infection

Edit search filters
  1. Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection

    Scottsdale/Phoenix, AZ

  2. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)

    Jacksonville, FL

  3. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

    Rochester, MN

  4. SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

    Rochester, MN

  5. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

    Scottsdale/Phoenix, AZ

  6. A Study Using VE303 to Prevent Recurrence of Clostridium Difficile Infection

    Rochester, MN

  7. Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects with Recurrence of Clostridium difficile Infection

    Rochester, MN

  8. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

    Scottsdale/Phoenix, AZ

  9. ECOSPOR IV: An Open-Label Extension of Study SERES 0012 Evaluating SER-109 in Subjects With Recurrent Clostridium Difficile Infection

    Rochester, MN

  10. ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection

    Rochester, MN

.

Mayo Clinic Footer